Expert Review of Anti-Infective Therapy, published by Taylor & Francis Ltd, is a leading journal in the field of infectious diseases, microbiology, and virology, boasting an impressive impact factor and ranking in the Q1 category across multiple disciplines. With an ISSN of 1478-7210 and E-ISSN 1744-8336, this journal has become a vital resource for researchers, professionals, and students aiming to advance their understanding of anti-infective therapies. Since its inception in 2003, the journal has provided critical insights, evidence-based reviews, and forward-thinking perspectives that contribute significantly to the ongoing efforts in combating infectious diseases. As of 2023, it ranks #36 out of 344 in Medicine/Infectious Diseases and maintains high percentiles in various other categories, reflecting its influence and reach within the scientific community. Although not an Open Access journal, its rich content is delivered through various academic libraries, sustaining its commitment to disseminating knowledge in the face of global health challenges. For those committed to innovation in the field, the Expert Review of Anti-Infective Therapy offers a platform that blends thorough research with practical applications, making significant strides in the fight against infectious pathogens.

Expert Review of Anticancer Therapy, published by Taylor & Francis Ltd, is a distinguished journal focusing on the dynamic and ever-evolving field of oncology and pharmacology. Since its inception in 2001, this journal has played a pivotal role in disseminating critical reviews and analyses of novel anticancer therapies, fostering a deeper understanding among researchers and practitioners alike. With an impressive categorization in the 2023 Q2 quartiles for both Oncology and Pharmacology, it ranks #98 out of 272 in Pharmacology and #165 out of 404 in Oncology according to Scopus metrics, placing it well within the upper echelons of academic journals. The journal’s rigorous peer-review process ensures high-quality publications that are integral for advancing cancer research and therapeutic strategies. Although currently not an open access journal, it aims to bridge the gap between scientific discovery and clinical application, making it an essential resource for anyone involved in the fight against cancer.

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

Optics and Spectroscopy is a pivotal peer-reviewed journal published by Pleiades Publishing Inc, focusing on the intricate fields of atomic and molecular physics, as well as optics. Established in 1972, and enjoying a legacy of convergence periods that reinforce its commitment to the evolving landscape of these scientific domains, the journal aims to disseminate high-quality research that advances our understanding of light-matter interactions, electronic materials, and spectroscopic techniques. Despite its current Q4 categorization in both the Atomic and Molecular Physics and Electronic, Optical and Magnetic Materials fields, with corresponding Scopus rankings reflecting its developing influence, the journal remains a valuable resource for researchers and professionals seeking to publish their findings, explore new methodologies, and connect with a community dedicated to innovation in optics. Although there is currently no open access option, the journal's expansive readership and its stability in publication over the decades make it an important platform for both established and emerging researchers in the field.

Optica Pura y Aplicada, published by the SOC ESPANOLA OPTICA, stands as a vital platform for the dissemination of cutting-edge research in the fields of Atomic and Molecular Physics, Optics, and related engineering disciplines. Established in Spain, this journal aims to foster the advancement of knowledge in optical science and technology by providing a rigorous peer-reviewed publication outlet for scholars, researchers, and practitioners. Despite being categorized in the Q4 quartile across multiple domains, including Engineering and Materials Science, the journal remains committed to contributing meaningful insights and advancements within its scope. With an ISSN of 0030-3917 and an E-ISSN of 2171-8814, the journal effectively reaches a global audience eager to explore innovative applications and theoretical developments in optics and materials science. Researchers and professionals alike will find in Optica Pura y Aplicada a valuable resource for enriching their understanding and practices in an ever-evolving field, fostering collaborations and promoting research growth until its converged conclusion in 2024.

LASERS IN SURGERY AND MEDICINE, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the field of laser technology in surgical and medical applications. With an impactful contribution to research since its inception in 1980, this journal has maintained a strong presence in high-impact categories, achieving Q1 status in both Dermatology and Surgery as of 2023. The journal is highly regarded, ranking #69 out of 551 in Medicine—Surgery and #21 out of 142 in Medicine—Dermatology within Scopus, indicating its significant influence in shaping contemporary surgical practices. Although it does not currently offer open access, subscribers and institutions can access a wealth of knowledge through its rigorous publication standards and high-quality research articles. Perfect for researchers, professionals, and students, LASERS IN SURGERY AND MEDICINE is an essential resource for those looking to stay at the forefront of innovations in laser applications across various medical fields.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.

MOLECULAR CANCER THERAPEUTICS, published by the American Association for Cancer Research, is a premier journal dedicated to advancing the field of cancer research and therapy since 2001. With a notable impact factor reflecting its high-quality content, this journal stands out in the Q1 category for both Cancer Research and Oncology as of 2023. Researchers, clinicians, and students interested in innovative treatment strategies and molecular mechanisms can find valuable insights within its pages, bolstered by a rigorous peer-review process and a global perspective on cancer therapeutic developments. Although the journal operates under a subscription model, it provides comprehensive access to cutting-edge studies and reviews that drive forward the understanding of cancer biology and treatment modalities. The journal's impressive Scopus rankings further validate its influence within both oncology and the broader cancer research community, making it an indispensable resource for anyone committed to combating cancer through science.